Such active ingredients may influence neuroactive ligand-receptor interaction, calcium signaling pathways, signaling pathways in cancer, cAMP signaling pathways, and PI3K pathways by acting on multiple targets such as PTGS2, PIK3CA, PIK3CB, PIK3CD, F2, and AR to treat migraine. The gene discussed is PIK3CB; the disease is migraine disorder.